Status:

COMPLETED

Impact of Mass Zinc Fortification Programs on Plasma Zinc Concentration

Lead Sponsor:

University of California, Davis

Collaborating Sponsors:

Helen Keller International

Cheikh Anta Diop University, Senegal

Conditions:

Zinc Deficiency

Eligibility:

MALE

18-65 years

Phase:

PHASE4

Brief Summary

The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of mass zinc fortification programs.

Detailed Description

The objectives of the present study are to determine whether plasma zinc concentration changes in response to additional zinc consumption, as provided by zinc-fortified cereal-based complementary food...

Eligibility Criteria

Inclusion

  • apparently healthy males

Exclusion

  • Hemoglobin \<80 g/L

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2010

Estimated Enrollment :

132 Patients enrolled

Trial Details

Trial ID

NCT00944723

Start Date

August 1 2009

End Date

February 1 2010

Last Update

February 19 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Helen Keller International

Dakar, Senegal